Literature DB >> 8880996

KSHV sequences in biopsies and cultured spindle cells of epidemic, iatrogenic and Mediterranean forms of Kaposi's sarcoma.

M G Aluigi1, A Albini, S Carlone, L Repetto, R De Marchi, A Icardi, M Moro, D Noonan, R Benelli.   

Abstract

The pathogenesis of Kaposi's sarcoma (KS) is still unclear, and several factors appear to be involved in the onset of the Kaposi's lesion. Epidemiological studies suggest that a common infective agent may contribute to KS. Sequences which appear to represent a new gammaherpesvirus, currently termed KSHV/HHV8, have recently been identified in KS. To further examine the relationship between this virus and KS, we obtained biopsy samples of KS lesions; these samples, the spindle cells cultured from these lesions and the PBMC of the same patients were tested for the presence of KSHV sequences by PCR. In addition, we tested several "late passage" KS spindle cell lines as well as control samples. The biopsy samples were from lesions of the following forms of KS: one sporadic KS, two epidemic KS and three iatrogenic KS, one of which was in the process of regressing after reduction of immunosuppressive therapy, and two that were at different stages (patch and nodular) from a single patient. The sporadic KS specimen was positive, as were the PBMCs from this patient, and cells grown from this biopsy appeared to contain KSHV viral sequences up to the fifth passage. Both epidemic KS biopsies were positive, but in these cases KSHV sequences were not detected in the cultured cells. The biopsy from the regressing iatrogenic KS lesion was negative, as were the cells cultured from this lesion. However, the PBMCs of this patient were weakly positive for KSHV at the time of biopsy, and PBMCs collected from this patient one month later were completely negative. The samples of both the patch and the nodular KS lesions obtained from another immunosuppressed patient showed amplifiable sequences of KSHV, but both the PBMCs of this patient and primary KS cell cultures from these biopsies were negative. Of the late-passage KS lines tested, only one, IST AIDS KS 12, was positive for KSHV. This line is derived from an early angiomatous-macula lesion. Taken together, these data suggest that an active KSHV infection is associated with KS and that elimination of KSHV from the lesion precedes regression of the lesion, strongly correlating KSHV with KS. In addition, early KS lesions may have a higher KSHV burden, or contain cells more susceptible to KSHV infection, further linking KSHV to KS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8880996     DOI: 10.1016/0923-2516(96)82285-0

Source DB:  PubMed          Journal:  Res Virol        ISSN: 0923-2516


  28 in total

1.  Human immunodeficiency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi's sarcoma-associated herpesvirus.

Authors:  V Varthakavi; P J Browning; P Spearman
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

2.  Extracellular Hsp90 serves as a co-factor for MAPK activation and latent viral gene expression during de novo infection by KSHV.

Authors:  Zhiqiang Qin; Michael DeFee; Jennifer S Isaacs; Chris Parsons
Journal:  Virology       Date:  2010-05-06       Impact factor: 3.616

3.  Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis.

Authors:  Adam Grundhoff; Don Ganem
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

4.  Direct and efficient cellular transformation of primary rat mesenchymal precursor cells by KSHV.

Authors:  Tiffany Jones; Fengchun Ye; Roble Bedolla; Yufei Huang; Jia Meng; Liwu Qian; Hongyi Pan; Fuchun Zhou; Rosalie Moody; Brent Wagner; Mazen Arar; Shou-Jiang Gao
Journal:  J Clin Invest       Date:  2012-02-01       Impact factor: 14.808

5.  Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo.

Authors:  Feng-Qi An; Hope Merlene Folarin; Nicole Compitello; Justin Roth; Stanton L Gerson; Keith R McCrae; Farnaz D Fakhari; Dirk P Dittmer; Rolf Renne
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

6.  Remodeling of endothelial adherens junctions by Kaposi's sarcoma-associated herpesvirus.

Authors:  Mandana Mansouri; Patrick P Rose; Ashlee V Moses; Klaus Früh
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

7.  Identification and Function of MicroRNAs Encoded by Herpesviruses.

Authors:  Zhi-Qiang Bai; Xiu-Fen Lei; Lin-Ding Wang; Shou-Jiang Gao
Journal:  Virol Sin       Date:  2008-12-01       Impact factor: 4.327

8.  Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation.

Authors:  Patrick A Carroll; Elizabeth Brazeau; Michael Lagunoff
Journal:  Virology       Date:  2004-10-10       Impact factor: 3.616

9.  Mapping and serodiagnostic application of a dominant epitope within the human herpesvirus 8 ORF 65-encoded protein.

Authors:  C P Pau; L L Lam; T J Spira; J B Black; J A Stewart; P E Pellett; R A Respess
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

10.  Kaposi's sarcoma-associated herpesvirus encodes a bZIP protein with homology to BZLF1 of Epstein-Barr virus.

Authors:  S F Lin; D R Robinson; G Miller; H J Kung
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.